These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11698587)

  • 41. Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction.
    Kapur A; Samaniego P; Thakur GA; Makriyannis A; Abood ME
    J Pharmacol Exp Ther; 2008 Apr; 325(1):341-8. PubMed ID: 18174385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies.
    Howlett AC; Song C; Berglund BA; Wilken GH; Pigg JJ
    Mol Pharmacol; 1998 Mar; 53(3):504-10. PubMed ID: 9495818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.
    Basavarajappa BS; Hungund BL
    Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.
    Andersson H; D'Antona AM; Kendall DA; Von Heijne G; Chin CN
    Mol Pharmacol; 2003 Sep; 64(3):570-7. PubMed ID: 12920192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.
    Hermann H; Marsicano G; Lutz B
    Neuroscience; 2002; 109(3):451-60. PubMed ID: 11823058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.
    Savinainen JR; Saario SM; Niemi R; Järvinen T; Laitinen JT
    Br J Pharmacol; 2003 Dec; 140(8):1451-9. PubMed ID: 14623770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor.
    Kabbani N; Negyessy L; Lin R; Goldman-Rakic P; Levenson R
    J Neurosci; 2002 Oct; 22(19):8476-86. PubMed ID: 12351722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
    Paquette JJ; Wang HY; Bakshi K; Olmstead MC
    Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists.
    Gullapalli S; Amrutkar D; Gupta S; Kandadi MR; Kumar H; Gandhi M; Karande V; Narayanan S
    Neuropharmacology; 2010 Jun; 58(8):1215-9. PubMed ID: 20214912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
    Zhou D; Song ZH
    J Neurosci Res; 2001 Aug; 65(4):346-53. PubMed ID: 11494371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
    Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J; Urban L; Bevan S; Nagy I
    Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways.
    Bouaboula M; Bianchini L; McKenzie FR; Pouyssegur J; Casellas P
    FEBS Lett; 1999 Apr; 449(1):61-5. PubMed ID: 10225429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacology of cannabinoid CB1 and CB2 receptors.
    Pertwee RG
    Pharmacol Ther; 1997; 74(2):129-80. PubMed ID: 9336020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.